Abstract：【Objective】To explore the application value of metallothionein-3 (MT-3) combined with tumor markers in evaluating the postoperative efficacy of transcatheter arterial chemoembolization (TACE) for primary liver cancer.【Methods】A retrospective analysis was conducted on the clinical data of 80 TACE treated primary liver cancer patients admitted to the Fourth People's Hospital of Shaanxi Province from January 2019 to January 2022. They were divided into a control group and an uncontrolled group based on their clinical efficacy. Clinical data such as Age,gender,body mass index (BMI),Child Pugh grading of liver function,tumor site,number of tumors,degree of tumor cell differentiation,tumor type,serum total bilirubin (TBIL),and serum tumor markers [CYFRA21-1,Squamous cell carcinoma antigen (SCC),carcinoembryonic antigen (CEA),alpha fetoprotein (AFP),carbohydrate antigen 19-9 (CA19-9)],and serum MT-3 of two groups of patients were collected; The evaluation value of serum MT-3 combined with tumor markers in the postoperative efficacy of TACE in patients with primary liver cancer were analyzed using the receiver operating characteristic (ROC) curve.【Results】Among the 80 cases,65 patients(81.25%) were effectively treated and included in the control group;15 patients (18.75%) were included in the uncontrolled group due to ineffective treatment. There was no statistically significant difference (P>0.05) between the two groups in terms of gender,tumor diameter,number of tumors,tumor location,degree of tumor cell differentiation,tumor type,liver cirrhosis,proportion of Child Pugh grading of liver function,age,BMI,TBIL,CA19-9,CEA; The levels of CYFRA21-1,SCC,and AFP in the uncontrolled group were higher than those in the control group (P<0.05),while the levels of MT-3 were lower than those in the control group (P<0.05). The ROC curve analysis results show that CYFRA21-1,SCC,AFP,and MT-3 all have certain predictive value for the postoperative efficacy of TACE in patients with primary liver cancer.【Conclusions】CYFRA21-1,SCC,AFP,and MT-3 have certain predictive value for the postoperative efficacy of TACE in patients with primary liver cancer,and the combined predictive value is higher. Clinicians should pay close attention to them.
张莉静, 王沛. 金属硫蛋白-3联合肿瘤标志物在原发性肝癌TACE术后疗效评估中的应用价值[J]. 医学临床研究, 2023, 40(9): 1396-1399.
ZHANG Lijing, WANG Pei. The Application Value of Metallothionein-3 Combined with Tumor Markers in the Evaluation of Postoperative Efficacy of TACE for Primary Liver Cancer. JOURNAL OF CLINICAL RESEARCH, 2023, 40(9): 1396-1399.
2023, Vol. 40 
